There's an explosion of data & digital opportunities in Indian healthcare: Vasant Narasimhan, CEO, Novartis - The Economic Times
Don't foresee any disruptions due to Covid-19: Vasant Narasimhan, CEO, Novartis - The Economic Times
Amazon Web Services, Google, Microsoft cloud: How cloud services are boosting the pharma sector - BusinessToday - Issue Date: Apr 16, 2023
Can you hear me, pharma? Voice-enabled apps are on the rise—and please don't freak out about privacy | Fierce Pharma
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Novartis CEO Vas Narasimhan on M&A and Taking Earlier Risks on New Technology
Novartis CEO Jimenez to step down early next year | The Seattle Times
Novartis CEO Vasant Narasimhan on China's coronavirus outbreak
Six Questions For Novartis CEO Narasimhan :: Scrip
We're energized by the opportunity to be a key digital partner for India' - About Amazon India
Novartis CEO Vas Narasimhan Sees Remote-Work Hybrid Persisting After Pandemic - Bloomberg
Novartis CEO's $50 Billion of Deals Was Just the First Act - Bloomberg
Novartis to limit M&A spend to 5% of market value | Financial Times
Vas Narasimhan | LinkedIn
We need short-term launches to keep driving growth: Novartis CEO - BusinessToday
The 'student' of leadership who seeks to inspire his employees | Financial Times
Novartis's new chief sets sights on 'productivity revolution' | Financial Times
Klaus Moosmayer, Ph.D. | Novartis
Agenda Contributors | World Economic Forum
Novartis digital chief is turning his CEO's 'unbossed' plans into new platforms | Fierce Pharma
Novartis CEO says company starting strategic review of Sandoz generic drug unit
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
